Abstract:Elevated levels of fetal hemoglobin ameliorate the severity of sickle cell disease and β-thalassemia, fuelling interest in the mechanisms underpinning the fetal (γ) to adult (β) switch in β-like globin chain subtype. We have previously identified a tripartite protein complex consisting of p22 NF-E4, CP2 and ALY, collectively known as the stage selector protein (SSP) that binds to the proximal γ-promoters, and fosters the preferential expression of the γ-genes in fetal erythroid cells. We have also identified a 14 kDa isoform of the NF-E4 protein that plays a role in γ-gene repression by binding CP2 and sequestering it away from the γ-promoter, resulting in disassembly of the activator SSP complex. Despite the loss of SSP binding, we showed by chromatin immunoprecipitation (ChIP) analysis that p22 NF-E4 remained bound to the γ-promoter in this context. To determine whether p22 NF-E4 could serve as the cornerstone for assembly of a larger repressor complex in this setting, we analyzed the proteins that were co-immunoprecipitated with p22 NF-E4 from K562 cell extract by mass spectrometry. One protein identified was PRMT5, an arginine methyltransferase that has been linked to gene silencing by establishing repressive arginine methyl marks including symmetrical dimethylation of arginine 3 on histone H4 (H4R3me2s). We confirmed the interaction between the two endogenous proteins by direct co-immunoprecipitation, and co-localized p22 NF-E4 and PRMT5 to the γ-globin gene promoters by ChIP. In vitro methylation studies using PRMT5 co-immunoprecipitated with p22 NF-E4 confirmed that histone H4 was the major substrate of the enzyme complex in K562 cells. In accord with this, we demonstrated a marked increase in H4R3me2s at the γ-promoter by ChIP in the setting of enforced expression of wild type PRMT5, accompanied by silencing of γ-gene expression.

Activation of γ-globin expression by LncRNA-mediated ERF promoter hypermethylation in β-thalassemia

Genome-wide analysis of aberrantly expressed lncRNAs and miRNAs with associated co-expression and ceRNA networks in β-thalassemia and hereditary persistence of fetal hemoglobin

Activation of γ-globin expression by a common variant disrupting IKAROS-binding motif in β-thalassemia

Identification and characterization of CHD4-associated eRNA as a novel modulator of fetal hemoglobin levels in β-thalassemia

The Protein Methyltransferase Prmt5 Links Histone H4 Methylation to Dnmt3a-dependent DNA Methylation and Transcriptional Silencing of the Fetal Globin Genes

Human m6A-mRNA and lncRNA epitranscriptomic microarray reveal function of RNA methylation in hemoglobin H-constant spring disease

Long noncoding RNA <i>HBBP1</i> enhances -globin expression through the ETS transcription factor ELK1

Identification of a PRMT5-dependent repressor complex linked to silencing of human fetal globin gene expression.

Genome-wide methylation and gene-expression analyses in thalassemia

Long noncoding RNA HBBP1 enhances γ-globin expression through the ETS transcription factor ELK1

Transcription factors LRF and BCL11A independently repress expression of fetal hemoglobin

A Genetic Variant Ameliorates Β-Thalassemia Severity by Epigenetic-Mediated Elevation of Human Fetal Hemoglobin Expression

A natural DNMT1 mutation elevates the fetal hemoglobin level via epigenetic derepression of the γ-globin gene in β-thalassemia

Fibrillarin modulates fetal hemoglobin silencing

Upregulation of miR‐6747‐3p affects red blood cell lineage development and induces fetal hemoglobin expression by targeting BCL11A in β‐thalassemia

Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia

Genetic modifications of EGLN1 reactivate HbF production in β0-thalassemia/HbE

Heterochromatin Protein 1γ is a Novel Epigenetic Repressor of Human Embryonic Ɛ-Globin Gene Expression

Structural basis for human ZBTB7A action at the fetal globin promoter

3’HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression

3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression